Figure Gallery

Expression Pattern Search Results for myb

(247 figures with expression from 126 publications)
Publication	Data	Fish	Condition	Stage Range	Anatomy
Mouillesseaux et al., 2011	Fig. S1	la116Tg utp15^{la1908/la1908}; la116Tg	standard conditions	20-25 somites	intermediate cell mass of mesoderm
Bai et al., 2010	Fig. 3	la781Tg la781Tg + MO2-trim33 la781Tg + MO1-cdc73 + MO2-trim33	standard conditions standard conditions standard conditions	10-13 somites	erythroid lineage cell
Soza-Ried et al., 2010	Fig. 3	WT myb^{t25127/t25127}	standard conditions	Prim-5 to Protruding-mouth	hematopoietic multipotent progenitor cell whole organism
	Fig. 4	WT	standard conditions	Day 5	thymus hematopoietic multipotent progenitor cell
	Fig. 5	WT	standard conditions	Days 45-89	hematopoietic multipotent progenitor cell
Jin et al., 2009	Fig. 6	gata1a^m651/m651 gata1a^m651/m651 + MO1-tnnt2a	standard conditions control	Prim-15 to Day 4	post-vent region hematopoietic multipotent progenitor cell ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. 5	WT	standard conditions	Day 4	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
North et al., 2009	Fig. 1	WT tnnt2a^{unspecified/unspecified}	control chemical treatment: S-nitroso-N-acetyl-D-penicillamine chemical treatment: pharmaceutical	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 2	WT tnnt2a^{unspecified/unspecified}	standard conditions	Prim-25	ventral wall of dorsal aorta whole organism
	Fig. 4	WT tnnt2a^{unspecified/unspecified}	control chemical treatment: S-nitroso-N-acetyl-D-penicillamine	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 5	WT WT + MO1-nos1 WT + MO1-nos2a WT + MO2-nos1 WT + MO2-nos2a	standard conditions standard conditions standard conditions standard conditions control chemical treatment: S-methyl-L-thiocitrulline chemical treatment: pharmaceutical chemical treatment: N-[3-(aminomethyl)benzyl]acetamidine	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 3	WT	control chemical treatment: pharmaceutical chemical treatment: S-nitroso-N-acetyl-D-penicillamine	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
Peterkin et al., 2009	Fig. 1	WT	control	10-13 somites	common myeloid progenitor
	Fig. 3	WT WT + MO1-sox32	standard conditions control	10-13 somites	anterior lateral plate mesoderm
Bertrand et al., 2008	Fig. 7	la2Tg	standard conditions	Day 4	hematopoietic stem cell
	Fig. 5	la2Tg; sd2Tg sd2Tg; zf71Tg	standard conditions	Prim-15 to High-pec	common myeloid progenitor hematopoietic stem cell intermediate cell mass of mesoderm ventral wall of dorsal aorta
	Fig. 1	WT	standard conditions	Prim-5 to Protruding-mouth	blood island common myeloid progenitor hematopoietic stem cell intermediate cell mass of mesoderm ventral wall of dorsal aorta
Imamura et al., 2008	Fig. 5	WT tp53^zdf1/zdf1 WT + MO1-tert tp53^zdf1/zdf1 + MO1-tert	standard conditions control	Long-pec	intermediate cell mass of mesoderm
	Fig. 3	WT WT + MO1-tert	standard conditions control	Prim-15	ventral wall of dorsal aorta
Yeh et al., 2008	Fig. 5	WT	standard conditions	Prim-15	hematopoietic multipotent progenitor cell
Gardiner et al., 2007	Fig. 2	WT WT + MO2-klf17	standard conditions control	20-25 somites to Long-pec	whole organism
	Fig. 3	WT WT + MO2-klf17	standard conditions control	Prim-5	intermediate cell mass of mesoderm
Horsfield et al., 2007	Fig. S1	AB rad21a^nz171/nz171 (AB)	standard conditions	Prim-5	hematopoietic system
Qian et al., 2007	Fig. 6	WT WT + MO7-tal1	standard conditions control	Prim-15	ventral wall of dorsal aorta
	Fig. 2	WT	standard conditions	Prim-5	ventral wall of dorsal aorta